Morgan Stanley Motus Gi Holdings, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Oct 27, 2022	SELL	$4.8 - $7.24 $23,520 - $35,476	-4,900 Reduced 83.05%	1,000 $0
Q2 2022 Aug 15, 2022	SELL	$4.8 - $7.24 $23,520 - $35,476	-4,900 Reduced 83.05%	1,000 $0
Q1 2022 Oct 27, 2022	BUY	$6.3 - $9.86 $30,870 - $48,314	4,900 Added 490.0%	5,900 $2,000
Q1 2022 May 13, 2022	BUY	$6.3 - $9.86 $30,851 - $48,284	4,897 Added 488.24%	5,900 $2,000
Q4 2021 Feb 14, 2022	SELL	$8.58 - $15.54 $331,411 - $600,248	-38,626 Reduced 97.47%	1,003 $0
Q3 2021 Nov 15, 2021	BUY	$13.8 - $20.6 $546,880 - $816,357	39,629 New	39,629 $28,000

About Motus GI Holdings, Inc.

Ticker MOTS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 2,996,840
Description
Motus GI Holdings, Inc., a medical technology company, develops Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.

More about MOTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.